Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Resistance to chemotherapy: current progress]

M André1, F Michel, F Thys

  • 1Unité d'Oncologie, Cliniques Universitaires Saint-Luc, Bruxelles.

Acta Clinica Belgica
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parental expectations regarding the announcement of a diagnosis of a rare oral disease: a qualitative study in Marseille, France.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2026
Same author

Rehabilitation and return to activity after platelet-rich plasma injections in chronic tendinopathies: Consensus from international experts.

PM & R : the journal of injury, function, and rehabilitation·2026
Same author

Difficulties experienced by dentists and orthodontists regarding ethical issues when announcing the diagnosis of a rare oral disease: a qualitative study in Marseille, France.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2024
Same author

Carboxyhemoglobin half-life toxicokinetic profiles during and after normobaric oxygen therapy: On a swine model.

Toxicology reports·2024
Same author

[Bladder augmentation in the era of botulinum toxin: Indications and results].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Organ donation by Maastricht-III pediatric patients: Recommendations of the Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP) and Association des Anesthésistes Réanimateurs Pédiatriques d'Expression Française (ADARPEF). Part II: Specific organizational and technical considerations.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same journal

MEFV variants as phenotypic modifiers in ankylosing spondylitis: a genetic interaction analysis with HLA-B27.

Acta clinica Belgica·2026
Same journal

What Europe should (not) learn from the new Dietary Guidelines for Americans.

Acta clinica Belgica·2026
Same journal

Real-world evidence on In-hospital statin use and mortality in geriatric patients.

Acta clinica Belgica·2026
Same journal

TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer.

Acta clinica Belgica·2026
Same journal

A decade of insulin pump therapy in a Belgian paediatric diabetes centre: longitudinal outcomes and evolving practices.

Acta clinica Belgica·2026
Same journal

Pneumococcal vaccination in Belgian adults: a practical translation of the 2025 Superior Health Council guidelines.

Acta clinica Belgica·2026
See all related articles

Chemotherapy can cure some cancers, but relapse often occurs due to drug-resistant tumor cells. New strategies are emerging to overcome multidrug resistance (MDR) and improve patient outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Context:

  • Chemotherapy is a cornerstone in cancer treatment, offering potential for complete remission and cure.
  • Relapsed cancers often resist further treatment, posing a significant clinical challenge.
  • The development of drug-resistant tumor cells is a primary cause of treatment failure.

Purpose:

  • To review the mechanisms of multidrug resistance (MDR) in cancer.
  • To highlight recent advancements in understanding MDR.
  • To discuss novel therapeutic strategies aimed at overcoming drug resistance.

Summary:

  • Multidrug resistance (MDR) significantly limits the long-term efficacy of chemotherapy.
  • Recent research has elucidated key molecular mechanisms driving MDR.

Related Experiment Videos

  • Emerging therapeutic strategies targeting MDR are progressing to clinical trials.

    • Impact:

    • Improved understanding of MDR mechanisms can guide the development of more effective cancer therapies.
    • Novel strategies may restore sensitivity to chemotherapy in resistant tumors.
    • Advancements in overcoming MDR hold promise for improving cure rates and patient survival in relapsed cancers.